SESEN BIO Forum: Community User: fb19077

@Gottbrain, Aveo Kohle bis Anfang 2020 safe

Ja hast recht sehr interessant aber es dauert ach noch sehr lange, bis 21 ist noch ein wenig zeit

Big Moves For Micro Sesen Bio In The Near Future - An Update $SESNhttps://seekingalpha.com/article/4247826

Interessanter Artikel.. Werde mich mal einlesen

Notfalls ziehe ich die Reißleine

Aveo hab ich noch Zweifel ob die Kohle reicht.

Habe Mitte Februar verpasst, bin erstmal bei Aveo und Sorrento rein

Stehe noch an der Seitenlinie, hoffe auf günstigeren Einstieg

Wird im Sommer interessant.

50 Mio Cash

http://ir.sesenbio.com/news-releases/news-release-details/sesen-bio-reports-fourth-quarter-and-full-year-2018-financial

Danke für die Info ✌️

Scynexis kannst du dir mal ansehen,25m mkp 50mille cash und im feb ph3 Prüfung,ist auch interressant.

Das Ding hat auf jeden Fall Potential zu dem es noch fast track designation hat,ich weiß allerdings nicht was die aktuell an cash haben.

Sesen Bio down 22% premarket on late-stage Vicinium datahttps://seekingalpha.com/news/3420273

I might be wrong but I believe that the SA Editor meant there were no statistically significant differences in the CRR between the Phase 3 VISTA trial and the earlier Phase 2 study results. So the editor is right. If you go back to look at the slide that compared the CRR between the P2 and P3, the bars on top of the bar chart overlapped and thus indicates non-statistical significant. In other words, both trials produce similar results and no statistically significant inference can be made between the two trials. In my view, it's quite likely that investors were expecting P3 to trump the P2 outcomes, which was not cased. Nonetheless, the P3 results were excellent. I'll go into further details in a future article. Best, Dr. Tran